Analytical Data
-
Gene name
MYH10
- Application
-
Alternative Names
MYH10；Myosin-10
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P35580
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYH10, a member of the myosin superfamily, encodes a non-muscle myosin heavy chain that plays a crucial role in cellular processes such as cell motility, division, and shape maintenance. Research into MYH10 has gained momentum due to its involvement in numerous physiological and pathological conditions, including cancer metastasis and developmental abnormalities. Dysregulation of MYH10 expression and activity has been implicated in various diseases, making it a potential therapeutic target. The study of MYH10 recombinant proteins helps elucidate its distinct functions and interactions within the cytoskeleton, providing insights into its mechanisms of action at the molecular level. By generating and characterizing MYH10 recombinant proteins, researchers aim to explore its role in cell dynamics, investigate the effects of specific mutations, and assess potential inhibitors that could modulate MYH10 activity. Such studies are essential not only for understanding basic cellular biology but also for identifying novel strategies for therapeutic interventions in diseases linked to MYH10 dysregulation.
